3billion
3billion, Inc. develops technology for rare disease drug discovery using bioinformatics and machine learning technology. The company focuses on developing methods for novel drug target discovery, drug candidate generation, and safety assessment. It offers genetic and biomolecular testing services related to the analysis of biologic samples of patients suspected to have rare genetic disorders, as … Read more
Market Cap & Net Worth: 3billion (394800)
3billion (KQ:394800) has a market capitalization of $325.78 Million (₩477.01 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #41015 globally and #2265 in its home market, demonstrating a 14.06% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying 3billion's stock price ₩15170.00 by its total outstanding shares 31444000 (31.44 Million).
3billion Market Cap History: 2025 to 2026
3billion's market capitalization history from 2025 to 2026. Data shows growth from $391.49 Million to $325.78 Million (0.00% CAGR).
3billion Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how 3billion's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 394800 by Market Capitalization
Companies near 3billion in the global market cap rankings as of March 19, 2026.
Key companies related to 3billion by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
3billion Historical Marketcap From 2025 to 2026
Between 2025 and today, 3billion's market cap moved from $391.49 Million to $ 325.78 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩325.78 Million | -16.79% |
| 2025 | ₩391.49 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of 3billion was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $325.78 Million USD |
| MoneyControl | $325.78 Million USD |
| MarketWatch | $325.78 Million USD |
| marketcap.company | $325.78 Million USD |
| Reuters | $325.78 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.